The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 952 participants.

Also called NCT02030418

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 952 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02030418
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02030418. Allocation not applicable; no masking; primary purpose treatment. Start 2014-02 (actual); primary completion 2015-06 (actual). Results posted on 2025-07-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker
Condition
Bradycardia
Intervention (Device)
Leadless Pacemaker
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02030418
Content hash
d6a82ed308da520012d01f9d50d2f9ecb78d3f64d3103ac25b39d5147da1ad09